This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
AMETEK (AME) Beats Q3 Earnings Estimates, Raises 2017 View
by Zacks Equity Research
AMETEK (AME) posts strong third-quarter results backed by robust organic growth and contributions from recently completed acquisitions.
Fiserv's (FISV) Q3 Earnings, Revenues Miss Estimates
by Zacks Equity Research
Fiserv's (FISV) Q3 results missed estimates due to declining periodic revenues and EMV deferrals. However, diversifying product portfolio and expanding clientele were tailwinds.
Garmin (GRMN) Tops Q3 Earnings Estimates, Raises 2017 View
by Zacks Equity Research
Garmin's (GRMN) strong third-quarter 2017 results were driven by its outdoor, marine and aviation product segments.
Top Ranked Growth Stocks to Buy for October 31st
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, October 31st:
Fortive (FTV) Beats on Q3 Earnings & Revenues, Guides Up
by Zacks Equity Research
Fortive's (FTV) third-quarter 2017 results were driven by strong revenue growth. Acquisitions contributed 1.8% to top-line growth.
KLA-Tencor (KLAC) Beats Earnings and Revenue Estimates in Q1
by Zacks Equity Research
KLA-Tencor's (KLAC) first-quarter fiscal 2018 results were driven by strong revenue growth and stable shipments.
Top Ranked Growth Stocks to Buy for October 27th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, October 27th:
Zacks.com featured highlights: Lam Research, Lear, Huntington Ingalls Industries, Lazard and Broadridge Financial Solutions
by Zacks Equity Research
Zacks.com featured highlights: Lam Research, Lear, Huntington Ingalls Industries, Lazard and Broadridge Financial Solutions
Zacks.com featured highlights: Lam Research, Xylem, Omega Healthcare Investors, Celanese and Electronic Arts
by Zacks Equity Research
Zacks.com featured highlights: Lam Research, Xylem, Omega Healthcare Investors, Celanese and Electronic Arts
Top Ranked Momentum Stocks to Buy for October 24th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, October 24th:
Earnings Picture Further Improves
by Sheraz Mian
It's not news that corporate earnings are good, but this earnings season is spotlighting two incrementally new positives to the earnings backdrop.
5 Best Stocks with Impressive Sales Growth to Buy Right Now
by Zacks Equity Research
Sales growth is an important indicator of a company's health and ability to sustain its business.
New Strong Buy Stocks for October 20th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Friday
Lam Research (LRCX) Tops Q1 Earnings & Revenue Estimates
by Zacks Equity Research
Lam Research (LRCX) delivers strong fiscal first-quarter results driven by strength in device architecture, process flow and advanced packaging technology inflections.
Top Ranked Momentum Stocks to Buy for October 18th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, October 18th:
New Strong Buy Stocks for October 17th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Tuesday
Why Earnings Season Could Be Great for Lam Research (LRCX)
by Zacks Equity Research
Investors are always looking for stocks that are poised to beat at earnings season and Lam Research (LRCX) may be one such company.
Can Strong Memory Save Lam Research (LRCX) in Q1 Earnings?
by Zacks Equity Research
Lam Research Corporation's (LRCX) first-quarter results are expected to benefit from the strong memory market. However, volatility in the PC market remains a concern.
3 Stocks Set for Higher Highs
by James Giaquinto
3 Stocks Set for Higher Highs
Are Tech Stocks Too Expensive?
by Sheraz Mian
Current tech sector valuation isn't cheap, it is nowhere near what it was back in the late-1990's, as you can see in the chart below.
Science Applications Wins Deal from Commonwealth of Virginia
by Zacks Equity Research
Science Applications (SAIC) wins $165 million worth contract from Virginia for modernization of the state's IT infrastructure.
Expedia Prices $1B Senior Notes, Gets Moody's Ba1 Rating
by Zacks Equity Research
Expedia Inc. (EXPE) offers $1 billion of senior unsecured notes. The move will help the company to bring down its cost of capital, thereby strengthening its balance sheet.
AMETEK (AME) Hits 52-Week High on Solid Product Portfolio
by Zacks Equity Research
AMETEK (AME) hits a new 52-week high of $66.64. The company's efforts toward expanding product portfolio through acquisitions and new product launches remain long-term drivers.
Anatomy of Success: Lam Research Corporation (LRCX)
by Brian Hamilton
At Zacks we stress the value of the Zacks Ranking system.
AppFolio Expands Product Offerings for Property Managers
by Zacks Equity Research
AppFolio (APPF) enhances product portfolio and partners with Amazon's Alexa.